Advance ZincTek (ASX:ANO) confirmed that pharmaceuticals, including zinc oxide, are exempt from the 10% US tariff under the Trump administration's executive orders, according to a Monday filing with the Australian bourse.
Accordingly, the company said that it does not expect any negative impact on its US operations related to the tariffs, the filing said.